Holen Sie sich die Stockscreener-App
0.63
1.61%
0.01
Schlusskurs vom Vortag:
$0.62
Offen:
$0.65
24-Stunden-Volumen:
67,656
Relative Volume:
0.34
Marktkapitalisierung:
$87.77M
Einnahmen:
$78.46M
Nettoeinkommen (Verlust:
$2.75M
KGV:
63.00
EPS:
0.01
Netto-Cashflow:
$-12.42M
1W Leistung:
+1.63%
1M Leistung:
+5.18%
6M Leistung:
+10.45%
1J Leistung:
-21.16%
1-Tages-Spanne:
$0.6151
$0.659
1-Wochen-Bereich:
$0.56
$0.67
52-Wochen-Spanne:
$0.331
$0.798
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Firmenname
Xtant Medical Holdings Inc
Sektor
Branche
Telefon
406-388-0480
Adresse
664 Cruiser Lane, Belgrade, MT
Vergleichen Sie XTNT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.63 | 86.37M | 78.46M | 2.75M | -12.42M | 0.01 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-05 | Eingeleitet | BTIG Research | Buy |
| 2018-11-15 | Bestätigt | Maxim Group | Buy |
| 2018-02-14 | Bestätigt | Maxim Group | Buy |
Xtant Medical Holdings Inc Aktie (XTNT) Neueste Nachrichten
What analysts say about Xtant Medical Holdings Inc. stockFree Consultation - jammulinksnews.com
Is Xtant Medical Holdings Inc. a good long term investmentUnstoppable profit momentum - jammulinksnews.com
Xtant Medical Holdings Inc. Stock Analysis and ForecastExplosive returns - jammulinksnews.com
What drives Xtant Medical Holdings Inc. stock priceOutstanding trading profits - jammulinksnews.com
Will Xtant Medical Holdings Inc. stock benefit from interest rate changesCapital Preservation Investment Ideas - Newser
What makes Xtant Medical Holdings Inc. stock price move sharplyStable Growth Stock Picks - Newser
Why Xtant Medical Holdings Inc. stock attracts strong analyst attention200 Percent Profit Outlook - Newser
How Xtant Medical Holdings Inc. stock performs during market volatilityPotential Rocket List - Newser
Craig-Hallum Remains a Buy on Xtant Medical Holdings (XTNT) - The Globe and Mail
Xtant Medical Sells Spinal Assets to Companion Spine - The Globe and Mail
Xtant Medical to sell spinal implant assets to Companion Spine By Investing.com - Investing.com South Africa
Companion Spine to acquire Paradigm Spine from Xtant Medical By Investing.com - Investing.com South Africa
Companion Spine LLC Announces Definitive Agreement to Acquire the Business and Assets of Paradigm Spine GmbH and the Coflex® and CoFix® Spine Implants from Xtant™ Medical Holdings, Inc. - BioSpace
Xtant Medical Agrees to Sell Certain Assets of Paradigm Spine to Companion Spine for $19.2 Million - MarketScreener
Xtant Medical To Sell Oflex, CoFix Implants And OUS Businesses To Companion Spine - Nasdaq
Xtant Medical to sell spinal implant assets to Companion Spine - Investing.com
Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine - Nasdaq
Companion Spine to acquire Paradigm Spine from Xtant Medical - Investing.com
Xtant Medical (NYSEAMERICAN:XTNT) Stock Crosses Above 200-Day Moving Average – Time to Sell? - Defense World
Is Xtant Medical Holdings, Inc. overvalued or undervalued? - MarketsMojo
Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
Xtant Medical Unveils OsteoFactor Pro for Bone Healing - Precedence Research
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Xtant Medical launches OsteoFactor Pro for bone repair By Investing.com - Investing.com South Africa
Xtant Medical Announces the Launch of OsteoFactor Pro™ - Ortho Spine News
Xtant Medical Holdings, Inc. Announces the Launch of OsteoFactor Pro - marketscreener.com
Xtant Medical launches OsteoFactor Pro for bone repair - Investing.com
Xtant Medical Introduces First-Ever Complete Orthobiologic Portfolio with New Bone Growth Technology - Stock Titan
Finanzdaten der Xtant Medical Holdings Inc-Aktie (XTNT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):